Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SIGMAR1 | Q99720 | 1/20 | 0.59 |
| ▸ | POLB | P06746 | 1/20 | 0.55 |
| ▸ | PPARG | P37231 | 1/20 | 0.52 |
| ▸ | PPARA | Q07869 | 1/20 | 0.52 |
| ▸ | MME | P08473 | 4/20 | 0.51 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.51 |
| ▸ | ACE | P12821 | 2/20 | 0.51 |
| ▸ | CPA1 | P15085 | 2/20 | 0.51 |
| ▸ | ACE2 | Q9BYF1 | 2/20 | 0.51 |
| ▸ | LMNA | P02545 | 1/20 | 0.50 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.50 |
| ▸ | HDAC3 | O15379 | 1/20 | 0.49 |
| ▸ | HDAC4 | P56524 | 1/20 | 0.49 |
| ▸ | HDAC1 | Q13547 | 1/20 | 0.49 |
| ▸ | HDAC2 | Q92769 | 1/20 | 0.49 |
| ▸ | HDAC8 | Q9BY41 | 1/20 | 0.49 |
| ▸ | NAALAD2 | Q9Y3Q0 | 1/20 | 0.49 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.48 |
| ▸ | BCHE | P06276 | 1/20 | 0.48 |
| ▸ | MMP2 | P08253 | 1/20 | 0.48 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL31688792 | 1.00 | SIGMAR1 (0.59) | SIGMAR1POLBPPARGPPARAMME | |
| SCHEMBL661567 | 1.00 | SIGMAR1 (0.59) | SIGMAR1POLBPPARGPPARAMME | |
| Hydrochloric Acid SCHEMBL28914437 | 0.98 | SIGMAR1 (0.57) | SIGMAR1POLBPPARGPPARAMME | |
| SCHEMBL668354 | 0.90 | BCHE (0.58) | SIGMAR1POLBMMEL3MBTL1ACE | |
| SCHEMBL668355 | 0.90 | BCHE (0.58) | SIGMAR1POLBMMEL3MBTL1ACE | |
| SCHEMBL7596254 | 0.89 | MME (0.57) | MMEL3MBTL1ACECPA1ACE2 | |
| SCHEMBL12207239 | 0.89 | MME (0.57) | MMEL3MBTL1ACECPA1ACE2 | |
| SCHEMBL3143813 | 0.89 | BCHE (0.54) | SIGMAR1POLBMMEL3MBTL1ACE | |
| SCHEMBL249802 | 0.89 | BCHE (0.54) | SIGMAR1POLBMMEL3MBTL1ACE | |
| SCHEMBL249801 | 0.89 | BCHE (0.54) | SIGMAR1POLBMMEL3MBTL1ACE |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 29 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230032216-A1 | INTERLEUKIN-4-INDUCED GENE 1 (IL4I1) AND RESPECTIVE METABOLITES AS BIOMARKERS FOR CANCER | Deutsches Krebsforschungszentrum Stiftung des oeffentlichen Rechts Im Neuenheimer Feld 280 (DE) | 2023-02-02 | — | — | US | claimed |
| EP-4073273-A1 | INTERLEUKIN-4-INDUCED GENE 1 (IL4I1) AND RESPECTIVE METABOLITES AS BIOMARKERS FOR CANCER | Deutsches Krebsforschungszentrum Stiftung des öffentlichen Rechts (DE) | 2022-10-19 | — | — | EP | claimed |
| CN-114901837-A | Interleukin-4 inducible gene 1(IL4I1) and corresponding metabolites as biomarkers for cancer | 德国癌症研究公共权益基金会 | 2022-08-12 | — | — | CN | claimed |
| WO-2021116357-A1 | INTERLEUKIN-4-INDUCED GENE 1 (IL4I1) AND RESPECTIVE METABOLITES AS BIOMARKERS FOR CANCER | Deutsches Krebsforschungszentrum Stiftung des öffentlichen Rechts (DE) | 2021-06-17 | — | — | WO | claimed |
| CN-101316509-A | Compounds and relative use for the control of phytopathogens | ISAGRO RICERCA SRL (IT) | 2008-12-03 | — | — | CN | claimed |
| CN-119716080-A | Radioactive enteritis differential metabolite marker based on fecal metabonomics, screening method and application thereof | 中山大学附属第六医院 | 2025-03-28 | — | — | CN | disclosed |
| CN-118897028-B | Biomarker for predicting gout attack risk and application thereof | 查理高特(青岛)健康科技有限公司 | 2025-03-28 | — | — | CN | disclosed |
| CN-118897028-A | Biomarker for predicting gout attack risk and application thereof | 查理高特(青岛)健康科技有限公司 | 2024-11-05 | — | — | CN | disclosed |
| US-20230032216-A1 | INTERLEUKIN-4-INDUCED GENE 1 (IL4I1) AND RESPECTIVE METABOLITES AS BIOMARKERS FOR CANCER | Deutsches Krebsforschungszentrum Stiftung des oeffentlichen Rechts Im Neuenheimer Feld 280 (DE) | 2023-02-02 | — | — | US | disclosed |
| EP-4073273-A1 | INTERLEUKIN-4-INDUCED GENE 1 (IL4I1) AND RESPECTIVE METABOLITES AS BIOMARKERS FOR CANCER | Deutsches Krebsforschungszentrum Stiftung des öffentlichen Rechts (DE) | 2022-10-19 | — | — | EP | disclosed |
| CN-114901837-A | Interleukin-4 inducible gene 1(IL4I1) and corresponding metabolites as biomarkers for cancer | 德国癌症研究公共权益基金会 | 2022-08-12 | — | — | CN | disclosed |
| WO-2021116357-A1 | INTERLEUKIN-4-INDUCED GENE 1 (IL4I1) AND RESPECTIVE METABOLITES AS BIOMARKERS FOR CANCER | Deutsches Krebsforschungszentrum Stiftung des öffentlichen Rechts (DE) | 2021-06-17 | — | — | WO | disclosed |
| EP-1259536-A2 | METHODS OF PEPTIDE PREPARATION | ALPHARMA AS (NO) | 2002-11-27 | — | — | EP | disclosed |
| WO-2001066147-A2 | ANTIMICROBIAL COMPOUNDS AND FORMULATIONS | ALPHARMA AS (NO) | 2001-09-13 | — | — | WO | disclosed |
| EP-1109831-A2 | CYCTOTOXIC PEPTIDES MODIFIED BY BULKY OR LIPOPHILIC MOIETIES | ALPHARMA AS (NO) | 2001-06-27 | — | — | EP | disclosed |
| EP-1109827-A2 | BIOACTIVE PEPTIDES | ALPHARMA AS (NO) | 2001-06-27 | — | — | EP | disclosed |
| WO-2001019852-A2 | METHODS OF PEPTIDE PREPARATION | ALPHARMA AS (NO) | 2001-03-22 | — | — | WO | disclosed |
| WO-2000012542-A2 | CYTOTOXIC LACTOFERRIN DERIVATIVES MODIFIED BY BULKY OR LIPOPHILIC MOIETIES | ALPHARMA AS (NO) | 2000-03-09 | — | — | WO | disclosed |
| WO-2000012541-A2 | CYTOTOXIC PEPTIDES MODIFIED BY BULKY OR LIPOPHILIC MOIETIES | ALPHARMA AS (NO) | 2000-03-09 | — | — | WO | disclosed |
| WO-1996000391-A1 | METHODS FOR THE SYNTHESIS OF DIKETOPIPERAZINES | AFFYMAX TECHNOLOGIES N.V. (AN) | 1996-01-04 | — | — | WO | disclosed |